Percorrer por autor "Santos, Ana Paula"
A mostrar 1 - 7 de 7
Resultados por página
Opções de ordenação
- Autonomia profissional e complementaridade funcional em enfermagem.Publication . Santos, Ana Paula; Martins, Catarina; Mariano, Daniela; Martins, João; Esteves, Susana
- Chronic Intestinal failure and short bowel syndrome in adults : the state of the artPublication . Vara-Luiz, Francisco; Glória, Luísa; Mendes, Ivo; Carlos, Sandra; Guerra, Paula; Nunes, Gonçalo; Oliveira, Cátia Sofia; Ferreira, Andreia; Santos, Ana Paula; Fonseca, JorgeBackground: Short bowel syndrome (SBS) is a devastating malabsorptive condition and the most common cause of chronic intestinal failure (CIF). During the intestinal rehabilitation process, patients may need parenteral support for months or years, parenteral nutrition (PN), or hydration/electrolyte supplementation, as a bridge for the desired enteral autonomy. Summary: Several classification criteria have been highlighted to reflect different perspectives in CIF. The management of CIF-SBS in adults is a multidisciplinary process that aims to reduce gastrointestinal secretions, slow transit, correct/prevent malnutrition, dehydration, and specific nutrient deficiencies, and prevent refeeding syndrome. The nutritional support team should have the expertise to take care of these complex patients: fluid support; oral, enteral, and PN; disease/PN-related complications; pharmacologic treatment; and surgical prevention/treatment. Key Messages: CIF-SBS is a complex disease with undesired consequences, if not adequately identified and managed. A comprehensive approach performed by a multidisciplinary team is essential to reduce PN dependence, promote enteral independence, and improve quality of life.
- Home parenteral support in chronic intestinal failure : first results from a pioneer Portuguese intestinal failure centerPublication . Mendes, Ivo; Vara-Luiz, Francisco; Palma, Carolina; Nunes, Gonçalo; Lima, Maria João; Oliveira, Cátia; Brito, Marta; Santos, Ana Paula; Santos, Carla Adriana; Fonseca, JorgeBackground/Objectives: Home parenteral support (HPS) is the core of chronic intestinal failure (IF) treatment. For legal reasons, HPS in Portugal lags behind other European countries, and only a few patients were taken care of at home by nurses. Now, the legislation has changed, allowing patient self-care. The authors report their pioneer experience as the largest Portuguese IF center, evaluating the underlying conditions leading to IF, HPS nutritional impact, HPS-related complications and survival. Methods: This is a retrospective study including IF patients who underwent HPS in a Portuguese IF center. The data included demographics, underlying conditions, IF types, HPS duration, BMI at the beginning and end of HPS/follow-up, complications, microbiological agents of infectious complications and current status (deceased or alive with/without HPS). Survival was calculated until death or September 2024. Results: A total of 23 patients (52.2% female, mean age 57.3 years), all with type III IF, were included. Short bowel syndrome (SBS) was the most common cause of IF (69.6%). Of the included patients, 78.3% received home parenteral nutrition; the others received home parenteral hydration. The mean BMI increased significantly, from 19.1 kg/m2 to 22.5 kg/m2 (p < 0.001). Two patients received Teduglutide. The most common complication was catheter-related bloodstream infection (2.5/1000 catheter days). The complications did not increase with patient self-care. At the end of follow-up, 21.7% of patients remained on HPS, 34.8% were alive without HPS, and 43.5% died. The average survival was 43.4 months. One death (4.35%) was attributable to HPS-related complications. Conclusions: The conditions underlying IF varied, with SBS being the most frequent condition. HPS improved the BMI, allowing considerable survival. Despite the complications and one attributable death, HPS was safe, even when relying on patient self-care.
- Long-term intestinal failure and home parenteral nutrition: a single center experiencePublication . Padinha, Mafalda; Oliveira, Cátia; Carlos, Sandra; Santos, Ana Paula; Brito, Marta; Santos, Carla Adriana; Fonseca, JorgeIntestinal failure is the reduction in gut function below the minimum necessary for the absorption of macronutrients and/or water electrolytes. The based treatment for type II and III intestinal failure patients is home parenteral nutrition (HPN) and hydration (HPH). This is a case-series study of HPN/HPH patients of the Hospital Garcia de Orta, Portugal, where thirteen patients present different underlying disorders and various IVS needs of nutrition and/or hydration. Most presented type III failure and most of them survived a long period under HPN and/or HNH.
- Long-term intestinal failure and home parenteral support : a single center experiencePublication . Brito, Mariana; Padinha, Mafalda; Carlos, Sandra; Oliveira, Cátia; Santos, Ana Paula; Nunes, Gonçalo; Santos, Carla Adriana; Fonseca, JorgeIntroduction: Home parenteral nutrition (HPN) and/or home parenteral hydration (HPH) are the gold-standard treatment for patients with long-term intestinal failure (IF). The authors aimed to assess the impact of HPN/HPH on nutritional status and survival of long-term IF patients, as well as HPN/HPH-related complications. Methods: This was a retrospective study including IF patients under HPN/HPH followed in a single large tertiary Portuguese hospital. The data collected included demographics, underlying conditions, anatomical characteristics, type and duration of parenteral support, IF functional, pathophysiological, and clinical classifications, body mass index (BMI) at the beginning and end of follow-up, complications/hospitalizations, current patient status (deceased, alive with HPN/HPH, and alive without HPN/HPH), and cause of death. Survival after HPN/HPH beginning, until death or August 2021, was recorded in months. Results: Overall 13 patients were included (53.9% female, mean age 63.46 years), and 84.6% of patients presented type III IF and 15.4% type II. Short bowel syndrome caused 76.9% of IF. Nine patients received HPN and 4 HPH. Eight patients (61.5%) were underweight at the beginning of HPN/HPH. At the end of follow-up, 4 patients were alive without HPN/HPH, 4 maintained HPN/HPH, and 5 died. All patients improved their BMI (mean initial BMI 18.9 vs. 23.5 at the end, p < 0.001). Eight patients (61.5%) were hospitalized due to catheter-related complications, mainly infectious (mean hospitalization episodes 2.25, mean hospital stay of 24.5 days). No deaths were related to HPN/HPH. Conclusion: HPN/HPH significantly improved IF patients’ BMI. HPN/HPH-related hospitalizations were common, however causing no deaths, reinforcing that HPN/HPH is an adequate and safe therapy for long-term IF patients.
- Projeto criar+ : escola a tempo inteiro no 2.º ciclo do ensino básicoPublication . Cabral Mendes, Pedro; Rebelo Leandro, Cristina; Campos, Francisco; Fachada, Miguel; Santos, Ana Paula
- Quando a futura mãe é RH- : perspectiva de enfermagem.Publication . Santos, Ana Paula; Martins, Catarina; Galante, Catarina; Martins, Ricardo; Marques, Fernanda Maria Gomes da Costa Teixeira